Page last updated: 2024-10-22

amobarbital and Myelopathy

amobarbital has been researched along with Myelopathy in 1 studies

Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sala, F1
Niimi, Y1
Berenstein, A1
Deletis, V1

Other Studies

1 other study available for amobarbital and Myelopathy

ArticleYear
Neuroprotective role of neurophysiological monitoring during endovascular procedures in the spinal cord.
    Annals of the New York Academy of Sciences, 2001, Volume: 939

    Topics: Algorithms; Amobarbital; Anesthetics, Local; Central Nervous System Vascular Malformations; Evoked P

2001